Skip to content

MAP Pharmaceuticals, Inc.

Delisted

CIK 1401923fmd_1C240YQZ2E2FVJ42MJ1RZKDXQCManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2004 to Sep 30, 2012, 16 periods

Latest annual · FY2011

Millions
Total revenues
23
Operating income
(33)
Net income
(33)

Latest quarter · Q3 FY2012

Millions
Total revenues
1
Operating income
(13)
Net income
(13)
Free cash flow
(11)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2008 to FY2011
n/m
Revenue, 5 yearsFY2006 to FY2011
n/m
Net income, 5 yearsFY2006 to FY2011
n/m

MAP Pharmaceuticals, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2011FY2010ChangeSource
Revenue$23.1 million10-K 2012-03-30 · proof
Operating income-$32.7 million-$53.5 million10-K 2012-03-30 · proof
Net income-$32.9 million-$54.7 million10-K 2012-03-30 · proof
What was MAP Pharmaceuticals, Inc.'s revenue in fiscal 2011?
MAP Pharmaceuticals, Inc. reported revenue of $23.1 million for fiscal 2011 (the year ended Dec 31, 2011). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
What was MAP Pharmaceuticals, Inc.'s operating income in fiscal 2011?
MAP Pharmaceuticals, Inc. reported operating income of -$32.7 million for fiscal 2011 (the year ended Dec 31, 2011), against -$53.5 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
What was MAP Pharmaceuticals, Inc.'s net income in fiscal 2011?
MAP Pharmaceuticals, Inc. reported net income of -$32.9 million for fiscal 2011 (the year ended Dec 31, 2011), against -$54.7 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2012. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1401923&period_type=annual&limit=5"

Information only, not investment advice.